The Visceral Analgesic Effect of Erector Spinae Plane Block in Laparoscopic Cholecystectomy
- Conditions
- Visceral Pain, Postoperative
- Interventions
- Drug: Ultrasound guided Rectus sheath blockDrug: Ultrasound erector spinae plane block
- Registration Number
- NCT03767816
- Lead Sponsor
- Asan Medical Center
- Brief Summary
The purpose of this study was to investigate the effectiveness of erector spinae plane block on postoperative visceral pain in laparoscopic cholecystectomy (LLC). Given that rectus sheath block may provide sufficient somatic pain block, investigators aimed to investigate whether erector spinae block is effective in visceral pain block.
After induction of general anesthesia, group of patient is decided randomly. In Group R, rectus sheath block is performed with 0.2% Ropivacaine 30ml before the operation. In Group RE, rectus sheath block and erector spinae plane block are performed with 0.2% ropivacaine 70ml before the operation.
NRS score measurement and comparison of the rescue analgesic dose used at 0, 0.5, 1, 2,6, 12, 18, and 24 hours after arrival at the recovery room were collected
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- adults between the ages of 20 and 80
- scheduled laparoscopic cholecystectomy patient
- American society of anesthesiologists score 1 or 2
- Patients who have voluntarily agreed in writing to participate in the trial
- Patient with side effects on local anesthetics or steroids
- Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc.
- Patients with uncontrolled medical or psychiatric problem
- Patient does not agree to participate in the study
- Patients with deformity at vertebra or chest wall.
- Patients who are pregnant or lactating
- Patients receiving a single laparoscopic cholecystectomy (including using a robot)
- Patients with severe intraperitoneal adhesion (higher than Nair s grade 3), or with external drain.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group RE: Rectus sheath block and erector spinae plane block Ultrasound erector spinae plane block ultrasound guided Rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml before surgical incision and ultrasound guided erector spinae plane block with 0.2% ropivacaine (Fresenius Kabi) 40ml Group RE: Rectus sheath block and erector spinae plane block Ultrasound guided Rectus sheath block ultrasound guided Rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml before surgical incision and ultrasound guided erector spinae plane block with 0.2% ropivacaine (Fresenius Kabi) 40ml Group R : Rectus sheath block group Ultrasound guided Rectus sheath block ultrasound guided Rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml before surgical incision
- Primary Outcome Measures
Name Time Method Difference of analgesic consumption between both group at 0, 0.5, 1, 2, 6, 12, 18, 24 hours after operation The difference in analgesics usage between the two groups after the operation is checked at fixed intervals (at 0, 0.5,
1, 2, 6, 12, 18, 24 hours after operation) to compare.
- Secondary Outcome Measures
Name Time Method compare the Numeric rating scale (NRS) at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation 10 years old or older. 0: No pain, 1-3: mild pain, 4-6: Moderate pain, 7-10: severe pain, 10: worst pain imaginable.
After surgery, the NRS differences between the two groups were compared at a constant interval (0, 0.5, 1, 2, 6, 12, 18, 24 hours postoperatively).
Trial Locations
- Locations (1)
Asan Medical Center
🇰🇷Seoul, Songpa-gu, Korea, Republic of